Brittney S. Harrington

926 total citations
19 papers, 393 citations indexed

About

Brittney S. Harrington is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Brittney S. Harrington has authored 19 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 11 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Brittney S. Harrington's work include Ubiquitin and proteasome pathways (4 papers), Cancer-related Molecular Pathways (4 papers) and Peptidase Inhibition and Analysis (3 papers). Brittney S. Harrington is often cited by papers focused on Ubiquitin and proteasome pathways (4 papers), Cancer-related Molecular Pathways (4 papers) and Peptidase Inhibition and Analysis (3 papers). Brittney S. Harrington collaborates with scholars based in Australia, United States and Japan. Brittney S. Harrington's co-authors include Christina M. Annunziata, John D. Hooper, Yaowu He, Vanessa Oakes, Brian Gabrielli, Alex Pinder, Sandra Pavey, Kee Ming Chia, Won‐Jae Lee and Heather Beamish and has published in prestigious journals such as Oncogene, Gut and International Journal of Molecular Sciences.

In The Last Decade

Brittney S. Harrington

19 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brittney S. Harrington Australia 10 211 132 87 56 42 19 393
Huayi Huang United States 13 217 1.0× 167 1.3× 102 1.2× 36 0.6× 57 1.4× 31 488
Duygu Derin Türkiye 12 178 0.8× 181 1.4× 81 0.9× 60 1.1× 31 0.7× 24 424
Xinlian Chen China 11 304 1.4× 81 0.6× 139 1.6× 52 0.9× 48 1.1× 33 495
Catherine Thériault Canada 9 211 1.0× 133 1.0× 38 0.4× 89 1.6× 66 1.6× 15 442
Kendall W Cradic United States 11 203 1.0× 83 0.6× 81 0.9× 50 0.9× 48 1.1× 19 492
Manon de Ladurantaye Canada 13 265 1.3× 156 1.2× 129 1.5× 77 1.4× 80 1.9× 17 574
Shang‐Lang Huang Taiwan 13 195 0.9× 111 0.8× 111 1.3× 65 1.2× 35 0.8× 23 445
Kelly A. Conrads United States 9 223 1.1× 77 0.6× 70 0.8× 24 0.4× 56 1.3× 23 467

Countries citing papers authored by Brittney S. Harrington

Since Specialization
Citations

This map shows the geographic impact of Brittney S. Harrington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brittney S. Harrington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brittney S. Harrington more than expected).

Fields of papers citing papers by Brittney S. Harrington

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brittney S. Harrington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brittney S. Harrington. The network helps show where Brittney S. Harrington may publish in the future.

Co-authorship network of co-authors of Brittney S. Harrington

This figure shows the co-authorship network connecting the top 25 collaborators of Brittney S. Harrington. A scholar is included among the top collaborators of Brittney S. Harrington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brittney S. Harrington. Brittney S. Harrington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Greer, Yoshimi Endo, Daniel R. Crooks, Ye Yang, et al.. (2025). Targeting metabolic vulnerability by combining NAMPT inhibitors and disulfiram for treatment of recurrent ovarian cancer. Cell Death and Disease. 16(1). 342–342. 2 indexed citations
2.
Greer, Yoshimi Endo, Teruhiko Yoshida, Brittney S. Harrington, et al.. (2024). Dual-inhibition of NAMPT and PAK4 induces anti-tumor effects in 3D-spheroids model of platinum-resistant ovarian cancer. Cancer Gene Therapy. 31(5). 721–735. 6 indexed citations
3.
Harrington, Brittney S., Soumya Korrapati, Jyoti Shetty, et al.. (2023). NF-κB Signaling Modulates miR-452-5p and miR-335-5p Expression to Functionally Decrease Epithelial Ovarian Cancer Progression in Tumor-Initiating Cells. International Journal of Molecular Sciences. 24(9). 7826–7826. 5 indexed citations
4.
Harrington, Brittney S., et al.. (2022). Disulfiram Transcends ALDH Inhibitory Activity When Targeting Ovarian Cancer Tumor-Initiating Cells. Frontiers in Oncology. 12. 14 indexed citations
5.
Kryza, Thomas, S. Lovell, Brittney S. Harrington, et al.. (2021). Substrate-biased activity-based probes identify proteases that cleave receptor CDCP1. Nature Chemical Biology. 17(7). 776–783. 16 indexed citations
6.
Wilson, Jennifer G., et al.. (2021). Clinic screening for adverse childhood experiences in people living with HIV to Improve Care Delivery. AIDS Care. 34(9). 1094–1102. 2 indexed citations
7.
Harrington, Brittney S., Michelle Ozaki, Lídia Hernandez, et al.. (2020). Drugs Targeting Tumor-Initiating Cells Prolong Survival in a Post-Surgery, Post-Chemotherapy Ovarian Cancer Relapse Model. Cancers. 12(6). 1645–1645. 30 indexed citations
8.
Harrington, Brittney S., et al.. (2019). 1268. Clinic Screening for Adverse Childhood Experiences among Persons with HIV: A Pilot Project. Open Forum Infectious Diseases. 6(Supplement_2). S456–S456. 1 indexed citations
9.
Harrington, Brittney S. & Christina M. Annunziata. (2019). NF-κB Signaling in Ovarian Cancer. Cancers. 11(8). 1182–1182. 87 indexed citations
10.
He, Yaowu, et al.. (2018). Evidence that cell surface localization of serine protease activity facilitates cleavage of the protease activated receptor CDCP1. Biological Chemistry. 399(9). 1091–1097. 3 indexed citations
11.
Chen, Yang, Brittney S. Harrington, Kevin Lau, et al.. (2017). Development of an enzyme-linked immunosorbent assay for detection of CDCP1 shed from the cell surface and present in colorectal cancer serum specimens. Journal of Pharmaceutical and Biomedical Analysis. 139. 65–72. 10 indexed citations
12.
Oancea, Iulia, Indrajit Das, Daniel Aguirre de Cárcer, et al.. (2016). Colonic microbiota can promote rapid local improvement of murine colitis by thioguanine independently of T lymphocytes and host metabolism. Gut. 66(1). 59–69. 62 indexed citations
13.
Wu, Andy, Yaowu He, Amy Broomfield, et al.. (2016). CD169+ macrophages mediate pathological formation of woven bone in skeletal lesions of prostate cancer. The Journal of Pathology. 239(2). 218–230. 35 indexed citations
14.
He, Yaowu, Brittney S. Harrington, & John D. Hooper. (2016). New crossroads for potential therapeutic intervention in cancer - intersections between CDCP1, EGFR family members and downstream signaling pathways. Oncoscience. 3(1). 5–8. 15 indexed citations
15.
Pinder, Alex, Dorothy Loo, Brittney S. Harrington, et al.. (2015). JIP4 is a PLK1 binding protein that regulates p38MAPK activity in G2 phase. Cellular Signalling. 27(11). 2296–2303. 9 indexed citations
16.
Harrington, Brittney S., et al.. (2014). Targeting the cell surface protein Cdcp1 in a model of advanced ovarian cancer. International Journal of Gynecological Cancer. 24(9). 113–113. 1 indexed citations
17.
Adams, Mark N., Brittney S. Harrington, Yaowu He, et al.. (2014). EGF inhibits constitutive internalization and palmitoylation-dependent degradation of membrane-spanning procancer CDCP1 promoting its availability on the cell surface. Oncogene. 34(11). 1375–1383. 28 indexed citations
18.
Oakes, Vanessa, Brittney S. Harrington, Won‐Jae Lee, et al.. (2014). Cyclin A/Cdk2 regulates Cdh1 and claspin during late S/G2 phase of the cell cycle. Cell Cycle. 13(20). 3302–3311. 66 indexed citations
19.
Dong, Ying, Brittney S. Harrington, Mark N. Adams, et al.. (2014). Activation of membrane-bound proteins and receptor systems: a link between tissue kallikrein and the KLK-related peptidases. Biological Chemistry. 395(9). 977–990. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huayi Huang Breakdown of academic impact, for papers by Duygu Derin Breakdown of academic impact, for papers by Xinlian Chen Breakdown of academic impact, for papers by Catherine Thériault Breakdown of academic impact, for papers by Kendall W Cradic Breakdown of academic impact, for papers by Manon de Ladurantaye Breakdown of academic impact, for papers by Shang‐Lang Huang Breakdown of academic impact, for papers by Kelly A. Conrads
Rankless by CCL
2026